Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term results of colorectal resection for slow transit constipation.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2013
Same author

Cytomegalovirus DNA among children attending two day-care centers in Tokyo.

Pediatrics international : official journal of the Japan Pediatric Society·2001
Same author

Erratum to "Murine fetal resorption and experimental pre-eclampsia are induced by both excessive Th1 and Th2 activation".

Journal of reproductive immunology·2001
Same author

Facultatively internal fertilization and anomalous embryonic development of a non-copulatory sculpin Hemilepidotus gilberti Jordan and Starks (Scorpaeniformes: Cottidae).

Journal of experimental marine biology and ecology·2001
Same author

Novel carbon-carbon bond formation reaction of methoxyallene oxide promoted by TiI(4)

Organic letters·2000
Same author

Nonlinear dielectric relaxation spectroscopy of ferroelectric liquid crystals

Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics·2000

Related Experiment Video

Updated: Jul 22, 2026

Ultrasound Imaging-guided Intracardiac Injection to Develop a Mouse Model of Breast Cancer Brain Metastases Followed by Longitudinal MRI
08:36

Ultrasound Imaging-guided Intracardiac Injection to Develop a Mouse Model of Breast Cancer Brain Metastases Followed by Longitudinal MRI

Published on: March 6, 2014

Radiotherapeutic Management of Brain Metastases from Breast Cancer.

Hayakawa1, Yamakawa, Mitsuhashi

  • 1Department of Radiology and Raiation Oncology, Gunma University School of Medicine, 3-39-22 Showa-Machi, Maebashi 371, Japan.

Breast Cancer (Tokyo, Japan)
|November 25, 2000
PubMed
Summary

Radiotherapy effectively treats brain metastases in breast cancer patients, improving neurological function in 92%. Long-term survival is possible, but careful management is needed to avoid severe complications.

More Related Videos

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
06:44

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging

Published on: June 7, 2020

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Related Experiment Videos

Last Updated: Jul 22, 2026

Ultrasound Imaging-guided Intracardiac Injection to Develop a Mouse Model of Breast Cancer Brain Metastases Followed by Longitudinal MRI
08:36

Ultrasound Imaging-guided Intracardiac Injection to Develop a Mouse Model of Breast Cancer Brain Metastases Followed by Longitudinal MRI

Published on: March 6, 2014

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
06:44

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging

Published on: June 7, 2020

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Area of Science:

  • Oncology
  • Radiation Oncology
  • Neurology

Background:

  • Brain metastases are a common complication of breast cancer.
  • Effective treatment strategies for breast cancer brain metastases are crucial for improving patient outcomes and quality of life.

Purpose of the Study:

  • To evaluate the efficacy and safety of radiotherapy for breast cancer patients with brain metastases.
  • To identify prognostic factors influencing survival in this patient population.

Main Methods:

  • Retrospective review of 28 breast cancer patients with brain metastases treated with radiotherapy between 1980 and 1994.
  • Radiotherapy included whole brain irradiation, with some patients receiving a boost or stereotactic irradiation.
  • Radiation doses ranged from 32 Gy to 60 Gy.

Main Results:

  • Neurologic functional improvement was observed in 92% of evaluable patients (12 complete response, 12 partial response).
  • Five-year survival from initial treatment was 39%, and 10-year survival was 16% (median survival 50 months).
  • Survival after brain metastasis treatment was 29% at 1 year and 18% at 2 years (median survival 6 months).
  • Liver metastasis was a significant negative prognostic factor (p=0.056).
  • Two patients experienced severe chronic complications: dementia and brain necrosis.

Conclusions:

  • Radiotherapy is an effective treatment for breast cancer brain metastases, leading to significant neurological improvement.
  • Long-term survival is achievable, even with extracranial metastases, excluding hepatic involvement.
  • Minimizing radiation-related complications is essential for optimizing patient outcomes.